---
title: "NAMS.US (NAMS.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/NAMS.US/news.md"
symbol: "NAMS.US"
name: "NAMS.US"
parent: "https://longbridge.com/zh-HK/quote/NAMS.US.md"
datetime: "2026-03-14T20:15:22.740Z"
locales:
  - [en](https://longbridge.com/en/quote/NAMS.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NAMS.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NAMS.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/NAMS.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/NAMS.US/news.md)


# NAMS.US (NAMS.US) — 相關新聞

### [Massive Insider Move at NewAmsterdam Pharma Shakes Up Investor Buzz](https://longbridge.com/zh-HK/news/277554086.md)
*2026-03-03T02:10:36.000Z*
> NewAmsterdam Pharma's CEO, Michael H. Davidson, sold 443,707 shares worth $14.75 million on March 2, 2026, raising inves

### [AOC Pharma S.à r.l. discloses transparency notification, revealing key details.](https://longbridge.com/zh-HK/news/277232252.md)
*2026-02-27T17:04:34.000Z*
> Authorities have reported a new record of daily COVID-19 cases in the country, with 10,362 new infections confirmed in t

### [Forecasting The Future: 4 Analyst Projections For NewAmsterdam Pharma Co](https://longbridge.com/zh-HK/news/276278010.md)
*2026-02-18T22:00:25.000Z*
> Analysts have provided mixed ratings for NewAmsterdam Pharma Co (NASDAQ:NAMS) over the past three months, with an averag

### [Earnings Summary: NewAmsterdam Pharma Co Q4](https://longbridge.com/zh-HK/news/276240509.md)
*2026-02-18T14:22:08.000Z*
> NewAmsterdam Pharma Co (NASDAQ:NAMS) reported its Q4 earnings on February 18, 2026, missing estimates by 65.79% with an 

### [Newamsterdam Pharma | 8-K: FY2025 Revenue: USD 22.5 M](https://longbridge.com/zh-HK/news/276224188.md)
*2026-02-18T12:02:28.000Z*